Chlamydia trachomatis infection in women with lichen sclerosus vulvae and vulvar cancer

Neuroendocrinology Letters

Volumn 30, Issue 5, 2009, Pages 671-674

  Olejek, Anita ^a   Kozak Darmas, Iwona ^a   Kellas Sleczka, Sylwia ^a,b   Jarek, Anna ^a   Wiczkowski, Andrzej ^a   Krol, Wojciech ^a   Stencel Gabriel, Krystyna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Institute of Oncology   (Poland)

Author keywords

Chlamydia trachomatis; Lichen sclerosus vulvae

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; LICHEN SCLEROSUS VULVA; MAJOR CLINICAL STUDY; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR; VULVA CANCER; VULVA DISEASE;

EID: 77649260635     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Al-Ghamdi A, Freedman D, Miller D Poh C, Rosin M, Zhang L et al. (2002). Vulvar quamosus cell carcinoma in young women: a clinicopathology study of 21 cases. Gynecol Oncol. 84: 94-101.
2. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikäheimo I et al. (2001). Serotypes of Chlamydia trachomatis and risk for development of cervical squamosus cell carcinoma. Jama. 285: 47-51.
3. Basta A, Adamek K, Pawlak M, Przeszlakowski D (1999). Incidence of precancerous states in carcinomas of the vulva in young woman. Przegl Lek. 56: 20-22.
4. Bieńkiewicz A, Gottwald L, Akoel KM, Lech W, Welfel J, Suzin J (2002). Clinical analysis of 105 cases of vulvar cancer. Ginekol Pol. 76(11): 913-918.
5. Boyle P, Leon ME, Maisonneuve P, Autier P (2003). Cancer control in women. Update 2003. Int J Gynaecol Obstet. 83: 179-202.
6. Canavan TP, Cohen D (2002). Vulvar cancer. Am Fam Physician. 66 (7): 1269-74.
7. Carli P, De Magnis A, Mannoe F, Botti E, Taddei G, Cattaneo A (2003). Vulvar carcinoma associated with lichen sclerosus. Experience at the Florence, Italy. Vulvar Clinic. J Reprod Med. 48(5): 313-318.
8. Carter J, Carlson J, Fowler J, Hartenbach E, Adcock L, Carson Let al. (1995). Invasive vulvar tumors in young women. A disease of immunosuppressed? Gynecol Oncol. 51: 307-10.
9. Ciszko B, Pochwalowski M, St Gabryś M (2006). Risk factors and clinical characteristic patients with vulvar cancer. Ginekol Pol. 77(12): 914-921.
10. Cocayne SE, Shah M, Slater DN, Harrington CI (1998). Spindle and pseudoglandular squamosus cell carcinoma arising in lichen sclerosus of the vulva. Br Dermatol. 138: 695-697.
11. Di Felice V, David S, Cappello F, Farina F, Zimmo G (2005). Is chlamydial heat shock protein 60 a risk factor for oncogenesis? Cell Mol Life Sci. 62(1): 4-9.
12. Fisher N (2002). Chlamydia trachomatis infection in cervical intraepithelial neoplasia and invasive carcinoma. Eur J Gynaecol Oncol. 23(3): 247-250.
13. Gastrell FH, McConell DT (2001). Human papillomavirus and intra-epithelial neoplasia. Best Pract Res Clin Obst Gynaec. 15: 769-782.
14. Joura EA, Losch A, Haider-Angeler MG, Breitenecker G, Leodolter S (2001). Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamosus cell carcinoma of the vulva in young women. J Reprod Med. 45(8): 613-615.
15. De Koning MN, Quint WG, Pirog EC (2008). Prevaelnce of mucosal and cutaneus human papillomaviruses in different histologic subtypes of vulvar cancer. Mod Pathol. 21(3): 334-344.
16. Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M et al. (2000). Chlamydia trachomatis infections as a rosk factor for invasive cervical cancer. Int J Cancer. 85: 35-39.
17. Kucinskiene V, Sutaite I, Valiukeviciene S, Milasauskiene Z, Domeika M. (2006). Prevalence and risk factors of genital Chlamydia trachomatis infection. Medicina (Kaunas). 42: (11): 885-894.
18. Madeleine MM, Anttila T, Schwartz SM, Saikku P, Leinonen M, Carter JJ et al. (2007). Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer. 120(3): 650-655.
19. Mardah PA, Novikova N (2001). Chlamydia trachomatis infections - a major concern for reproductive health. Where do we stand regarding epidemiology, pathogenesis and therapy? Eur J Contracept Reprod Health Care. 6: 115-126.
20. Ness RB, Goodman MT, Shen C, Brunham RC (2003). Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer. J Infect Dis. 187(7): 1147-1152.
21. Olejek A (2002). Bacterial flora in vulvar carcinoma with HPV 16 or HPV 18 infection. Hung J Gynaecol Oncol. 2: 173.
22. Pavonen J, Karunakaran KP, Noguchi Y, Anttila T, Bloigu A, Dillner J et al. (2003). Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women developing cervical cancer. Am J Obstet Gynecol. 189(5): 1287-1292.
23. Pisani P, Parkin DM, Munoz N, Ferlay J (1997). Cancer and infections: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Rev. 6: 387-400.
24. Schlott T, Eiffert H, Bohne W, Landgrebe J, Brunner E, Spielbauer B et al. (2005). Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue. Gynecol Oncol. 98(3): 409-419.
25. Smith YR, Haefner HK (2004). Vulvar lichen sclerosus: pathophysiology and treatment. Am J Clin Dermatol. 5: 105-125.
26. Smith JS, Herrero R, Bosetti C, Muñoz N, Bosch FX, Eluf-Neto J et al. (2002). Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst. 94: 1592-1593.
27. Velemínský M Jr, Přádná J, Velemínský M Sr, Tošner J (2008). Relationship of amniotic-type placentainflammation to pPROM, PROM and risk of early onset neonatal sepsis Neuroendocrinol Lett. 29 (4): 447-450.
28. Velemínský M Jr, Stránský P, Velemínský M Sr, Tošner J (2008). Relationship of IL-6, IL-8, TNF and sICAM-1 levels to PROM, pPROM, and the risk of early-onset neonatal sepsis. Neuroendocrinol Lett. 29(3): 303-311.
29. Wallin KL, Hallmans G, Luostarien T, Angström T, Anttila T, Bergman F et al. (2002). A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer. 101: 371-374
30. Zereu M, Zettler CG, Cambruzzi E, Zelmanowicz A (2007). Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix. Gynecol Oncol. 105(1): 172-175.
31. Zdrodowska-Stefonow B, Ostaszewska-Puchalska I, Pucio K (2003). The immunology of Chlamydia trachomatis. Arch Immunol Ther Exp. 51: 289-294.